Clinical Trial Update: A Description of Inflammatory Cell Types In Moderate to Severe Pediatric Asthma: Eosinophilic and Non Eosinophilic Sputum Markers While on Anti-IgE Therapy [Phase 4]

View source ↗

Summary

Phase 4 trial update describing inflammatory cell types in moderate to severe pediatric asthma while on anti-IgE therapy, focusing on eosinophilic and non-eosin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Asthma
• Asthma

Drugs mentioned

• Anti-IgE therapy

Snippet

Sponsor: Children's Hospital of The King's Daughters | Conditions: ALLERGIC ASTHMA | Phase 4 | Status: COMPLETED | Results posted: 2018-02-19